Oncogenesis and Molecular Virology Unit, Institut Pasteur, Inserm U579, 28 rue du Dr. Roux, 75724 Paris cedex 15, France.
Viruses. 2009 Dec;1(3):630-646. doi: 10.3390/v1030630. Epub 2009 Oct 30.
Epidemiological studies have provided overwhelming evidence for a causal role of chronic HBV infection in the development of hepatocellular carcinoma (HCC), but the molecular mechanisms underlying virally-induced tumorigenesis remain largely debated. In the absence of a dominant oncogene encoded by the HBV genome, indirect roles have been proposed, including insertional activation of cellular oncogenes by HBV DNA integration, induction of genetic instability by viral integration or by the regulatory protein HBx, and long term effects of viral proteins in enhancing immune-mediated liver disease. In this chapter, we discuss different models of HBV-mediated liver cell transformation based on animal systems of hepadnavirus infection as well as functional studies in hepatocyte and hepatoma cell lines. These studies might help identifying the cellular effectors connecting HBV infection and liver cell transformation.
流行病学研究为慢性乙型肝炎病毒(HBV)感染在肝细胞癌(HCC)发展中的因果作用提供了压倒性的证据,但病毒诱导肿瘤发生的分子机制仍存在很大争议。在 HBV 基因组中没有编码显性癌基因的情况下,人们提出了间接作用,包括 HBV DNA 整合激活细胞癌基因、病毒整合或调节蛋白 HBx 诱导遗传不稳定性,以及病毒蛋白在增强免疫介导的肝病方面的长期作用。在本章中,我们讨论了基于动物庚型肝炎病毒感染系统以及在肝细胞和肝癌细胞系中的功能研究的 HBV 介导的肝细胞转化的不同模型。这些研究可能有助于确定将 HBV 感染与肝细胞转化联系起来的细胞效应物。